- The Asia-Pacific surgical sealants and adhesives market is witnessing robust growth, fueled by the increasing volume of surgeries, rising healthcare expenditures, and the growing focus on minimally invasive procedures. As patient outcomes and reduced recovery time gain importance, the adoption of effective wound closure materials is expanding rapidly.
- Technological advancements are enhancing the performance of surgical adhesives by improving their biocompatibility, adhesion strength, and biodegradability. Innovations like polyethylene glycol (PEG)-based sealants and fibrin glues are being widely adopted for internal and external surgical applications.
- Major countries in the region—including China, Japan, India, and South Korea—are investing in healthcare infrastructure and expanding their surgical facilities, leading to increased demand for advanced hemostatic agents and surgical sealants.
- For instance, in January 2024, India's Health Ministry announced an initiative to upgrade 157 district hospitals with advanced surgical care units under the PM-Ayushman Bharat Health Infrastructure Mission. This move is expected to drive demand for high-performance surgical adhesives used in wound management and post-operative care.
Frequently Asked Questions
Japan is expected to dominate the Asia-Pacific surgical sealants and adhesives market, driven by advanced healthcare infrastructure, a strong presence of medical technology companies, and a high demand for surgical adhesives in surgeries such as orthopedics, cardiac, and general surgery.
China is expected to experience the highest growth rate in the Asia-Pacific surgical sealants and adhesives market due to the country’s expanding healthcare infrastructure and rising surgical procedures across various specialties.
The major factors driving the growth of the aerospace interior adhesive market are the rising surgical procedures across the region and rising surgical volume and demand for faster post-operative recovery .
